Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response

By Johansson B.E.   Matthews J.T.   Kilbourne E.D.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 1009-1015

Elsevier

Access to resources Recommend Favorite

Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine

By Johansson B.E.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 2073-2080

Elsevier

Access to resources Recommend Favorite

Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children

By Boyce T.G.   Gruber W.C.   Coleman-Dockery S.D.   Sannella E.C.   Reed G.W.   Wolff M.   Wright P.F.  

Vaccine, Vol. 18, Iss. 1, 1999-08 ,pp. : 82-88

Elsevier

Access to resources Recommend Favorite

Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans

By Kilbourne E.D.   Couch R.B.   Kasel J.A.   Keitel W.A.   Cate T.R.   Quarles J.H.   Grajower B.   Pokorny B.A.   Johansson B.E.  

Vaccine, Vol. 13, Iss. 18, 1995-01 ,pp. : 1799-1803

Elsevier

Access to resources Recommend Favorite

DDA adjuvant induces a mixed Th1/Th2 immune response when associated with BBG2Na, a respiratory syncytial virus potential vaccine

By Klinguer-Hamour C.   Libon C.   Plotnicky-Gilquin H.   Bussat M.-C.   Revy L.   Nguyen T.   Bonnefoy J.-Y.   Corvaa N.   Beck A.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2743-2751

Elsevier

Access to resources Recommend Favorite